BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 2308001)

  • 1. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
    Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
    J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolic studies of gliomas with positron emission tomography and phosphorus 31 MR spectroscopy in diagnosis and treatment planning].
    Jeske J; Herholz K; Heindel W; Heiss WD
    Onkologie; 1989 Aug; 12 Suppl 1():42-5. PubMed ID: 2685695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
    Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
    Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
    Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
    Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.
    Imani F; Boada FE; Lieberman FS; Davis DK; Deeb EL; Mountz JM
    J Neuroimaging; 2012 Apr; 22(2):184-90. PubMed ID: 21155917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
    Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
    Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
    Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
    No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
    Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
    Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma.
    Barker FG; Chang SM; Valk PE; Pounds TR; Prados MD
    Cancer; 1997 Jan; 79(1):115-26. PubMed ID: 8988735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional methionine and glucose uptake in high-grade gliomas: a comparative study on PET-guided stereotactic biopsy.
    Goldman S; Levivier M; Pirotte B; Brucher JM; Wikler D; Damhaut P; Dethy S; Brotchi J; Hildebrand J
    J Nucl Med; 1997 Sep; 38(9):1459-62. PubMed ID: 9293808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value positron emission tomography with [18F]fluoro-2-deoxy-D-glucose in the low-grade glioma.
    De Witte O; Levivier M; Violon P; Salmon I; Damhaut P; Wikler D; Hildebrand J; Brotchi J; Goldman S
    Neurosurgery; 1996 Sep; 39(3):470-6; discussion 476-7. PubMed ID: 8875476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
    Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K
    No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
    J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose.
    Woesler B; Kuwert T; Morgenroth C; Matheja P; Palkovic S; Schäfers M; Vollet B; Schäfers K; Lerch H; Brandau W; Samnick S; Wassmann H; Schober O
    Eur J Nucl Med; 1997 Apr; 24(4):428-34. PubMed ID: 9096095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using 18F-fluorodeoxyglucose and 11C-L-methylmethionine.
    Derlon JM; Petit-Taboué MC; Chapon F; Beaudouin V; Noël MH; Creveuil C; Courtheoux P; Houtteville JP
    Neurosurgery; 1997 Feb; 40(2):276-87; discussion 287-8. PubMed ID: 9007859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging of juvenile pilocytic astrocytomas: an enigma.
    Fulham MJ; Melisi JW; Nishimiya J; Dwyer AJ; Di Chiro G
    Radiology; 1993 Oct; 189(1):221-5. PubMed ID: 8372197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
    Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
    Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of survival in glioma patients by means of positron emission tomography.
    Patronas NJ; Di Chiro G; Kufta C; Bairamian D; Kornblith PL; Simon R; Larson SM
    J Neurosurg; 1985 Jun; 62(6):816-22. PubMed ID: 2987440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET-FDG of pleomorphic xanthoastrocytoma.
    Bicik I; Raman R; Knightly JJ; Di Chiro G; Fulham MJ
    J Nucl Med; 1995 Jan; 36(1):97-9. PubMed ID: 7799091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.